Ovid Therapeutics Inc.·4

Jun 10, 7:49 PM ET

Rona Jeffrey A 4

4 · Ovid Therapeutics Inc. · Filed Jun 10, 2021

Insider Transaction Report

Form 4
Period: 2021-06-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-02+100,000100,000 total
    Exercise: $4.42Exp: 2031-06-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on June 2, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION